GB0017512D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0017512D0
GB0017512D0 GBGB0017512.5A GB0017512A GB0017512D0 GB 0017512 D0 GB0017512 D0 GB 0017512D0 GB 0017512 A GB0017512 A GB 0017512A GB 0017512 D0 GB0017512 D0 GB 0017512D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0017512.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GBGB0017512.5A priority Critical patent/GB0017512D0/en
Publication of GB0017512D0 publication Critical patent/GB0017512D0/en
Priority to AU2001276392A priority patent/AU2001276392A1/en
Priority to PCT/EP2001/007967 priority patent/WO2002006338A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB0017512.5A 2000-07-17 2000-07-17 Novel compounds Ceased GB0017512D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0017512.5A GB0017512D0 (en) 2000-07-17 2000-07-17 Novel compounds
AU2001276392A AU2001276392A1 (en) 2000-07-17 2001-07-11 Vaccine comprising a lung tumour associated antigen
PCT/EP2001/007967 WO2002006338A1 (en) 2000-07-17 2001-07-11 Vaccine comprising a lung tumour associated antigen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0017512.5A GB0017512D0 (en) 2000-07-17 2000-07-17 Novel compounds

Publications (1)

Publication Number Publication Date
GB0017512D0 true GB0017512D0 (en) 2000-08-30

Family

ID=9895804

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0017512.5A Ceased GB0017512D0 (en) 2000-07-17 2000-07-17 Novel compounds

Country Status (3)

Country Link
AU (1) AU2001276392A1 (en)
GB (1) GB0017512D0 (en)
WO (1) WO2002006338A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201319446D0 (en) * 2013-11-04 2013-12-18 Immatics Biotechnologies Gmbh Personalized immunotherapy against several neuronal and brain tumors
GB201520592D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520568D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd Peptides
CR20190388A (en) * 2017-01-27 2019-10-16 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
EP3658576A1 (en) * 2017-07-25 2020-06-03 IDP Discovery Pharma, S.L. Anticancer peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087168A (en) * 1999-01-20 2000-07-11 Cedars Sinai Medical Center Conversion of non-neuronal cells into neurons: transdifferentiation of epidermal cells

Also Published As

Publication number Publication date
WO2002006338A1 (en) 2002-01-24
AU2001276392A1 (en) 2002-01-30

Similar Documents

Publication Publication Date Title
AU7476301A (en) Novel compounds
EP1276755A4 (en) Novel compounds
GB0003019D0 (en) Novel compounds
AU9261901A (en) Novel compounds
EP1255771A4 (en) Novel compounds
GB0008464D0 (en) Novel compounds
EP1292617A4 (en) Novel compounds
EP1472352A4 (en) Novel compounds
EP1343813A4 (en) Novel compounds
AU7476401A (en) Novel compounds
EP1276866A4 (en) Novel compounds
GB0004149D0 (en) Novel compounds
EP1299530A4 (en) Novel compounds
GB0003636D0 (en) Novel compounds
GB0001898D0 (en) Novel compounds
GB0004196D0 (en) Novel compounds
GB0002402D0 (en) Novel compounds
EG22332A (en) Novel compounds
GB0006577D0 (en) Novel compounds
GB0007903D0 (en) Novel compounds
GB0001936D0 (en) Novel compounds
GB0002096D0 (en) Novel compounds
GB0002191D0 (en) Novel compounds
GB0002195D0 (en) Novel compounds
GB0015359D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)